Botanical species · safety record

Saposhnikovia divaricata

The EFSA Compendium of Botanicals holds 9 constituent measurements for Saposhnikovia divaricata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Saposhnikovia divaricata (Turcz.) Schischk.

9Constituent measurements

0Safety records

3Cited sources

775Licensed products (Canada)

Also recorded as

Ledebouriella seseloides (Hoffm.) H. Wolff

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 775 licensed products naming Saposhnikovia divaricata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
solid

Source material stated

Dried root(s)
New material
Radix
Rhizome
Root
Root extract
Saposhnikovia divaricata root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Anomalin	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Bergapten	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Furanocoumarins	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Imperatorin	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Phellopterin	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Psoralen	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Marmesin	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Methoxsalen	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Methyleugenol	Roots and other underground parts	Essential oil	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Guo, Dean., Liu, Zhian., Lou, Zhicen. Constituents of Chinese drug Fangfeng, the root of Saposhnikovia divaricata. Journal of chinese pharmaceutical sciences, 1992, p. 81-83.
Kim, Min Kyung., Yang, Dong-Hyug., Jung, Mihye., Jung, Eun Ha., Eom, Han Young., Suh, Joon Hyuk., Min, Jung Won., Kim, Unyong., Min, Hyeyoung., Kim, Jinwoong., Han, Sang Beom. Simultaneous determination of chromones and coumarins in Radix Saposhnikoviae by high performance liquid chromatography with diode array and tandem mass detectors . Journal of chromatography a, 2011, vol. 1218, no. 37, p. 6319-6330. DOI
Gu, Li., Pan, Jiongguang., Yang, Jian., Xiao, Yongqing. GC-MS analysis of essential oils from roots of Saposhnikovia divaricata, Libanotis laticalycina, Seseli yunnanense and Peucedanum dielsianum. Zhongguo zhongyao zazhi, 1999, p. 678-680.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature